The Gout Stages 
EmpowHer
?Asymptomatic (without symptoms) hyperuricemia. In first stage of gout, a person has elevated levels of uric acid in the blood (hyperuricemia), but no other symptoms. Treatment is usually not required. ?Acute gout, or acute gouty arthritis.

 

Febuxostat (FEBURIC) Launches in Taiwan 
PharmaLive.com (press release)
Tokyo, Japan, May 10, 2012 --- Teijin Pharma Limited announced today the launch of febuxostat, a novel drug developed by Teijin Pharma for the treatment of hyperuricemia with gout, in Taiwan. Astellas Pharma Taiwan, Inc., the febuxostat licensee in ...

and more » 

Biopharma M&A Streak Continues: AstraZeneca Buys Ardea for $1.26B Cash 
BioWorld Online
The cash-cow target: Ardea's lesinurad, which is currently in Phase III development as a potential treatment for the chronic management of hyperuricemia in patients with gout. Ardea's stock (NASDAQ: RDEA) leapt 51 percent ahead of the Monday morning ...
AstraZeneca reels in promising PhIII gout drug in $1.26B Ardea buyout FierceBiotech
AstraZeneca buys Ardea Biosciences for $1.26 billion Drug Store News
AstraZeneca Reaches $1.26 Billion Deal for Ardea Biosciences New York Times (blog)
The Pharma Letter  -San Diego Business Journal 
all 341 news articles » 

Ardea Biosciences Announces First Quarter 2012 Financial Results 
MarketWatch (press release)
Ardea's most advanced clinical-stage product candidates include lesinurad, formerly known as RDEA594, a selective, oral URAT1 transporter inhibitor for the chronic management of hyperuricemia in patients with gout and BAY 86-9766, formerly known as ...

and more »